2013;145:128 39. 46. McGee EC, Gillinov AM, Blackstone EH, et al. Recurrent mitral regurgi- tation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg. 2004;128:916 24. 47. Miller DC. Ischemic mitral regurgitation redux to repair or to replace? J Thorac Cardiovasc Surg. 2001;122:1059 62. 48. Grayburn PA, Foster E, Sangli C, et al. Relationship between the mag- nitude of reduction in mitral regurgitation severity and left ventricular and left atrial reverse remodeling after MitraClip therapy. Circulation. 2013;128:1667 74. 49. Pibarot P, Delgado V, Bax JJ. MITRA-FR vs. COAPT: lessons from two tri- als with diametrically opposed results. Eur Heart J Cardiovasc Imaging. 2019;20:620 4. 50. Braun J, Bax JJ, Versteegh MI, et al. Preoperative left ventricular dimensions predict reverse remodeling following restrictive mitral annuloplasty in isch- emic mitral regurgitation. Eur J Cardiothorac Surg. 2005;27:847 53. 51. Kim D-H, Heo R, Handschumacher MD, et al. Mitral valve adaptation to isolated annular dilation: insights into the mechanism of atrial functional mitral regurgitation. JACC Cardiovasc Imaging. 2019;12:665 77. 52. Deferm S, Bertrand PB, Verbrugge FH, et al. Atrial functional mitral regurgita- tion: JACC review topic of the week. J Am Coll Cardiol. 2019;73:2465 76. 53. Gertz ZM, Raina A, Saghy L, et al. Evidence of atrial functional mitral re- gurgitation due to atrial fibrillation: reversal with arrhythmia control. J Am Coll Cardiol. 2011;58:1474 81. 8. TRICUSPID VALVE DISEASE 8.1. Classification and Stages of TR 1. Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long- term survival. J Am Coll Cardiol. 2004;43:405 9. 2. Topilsky Y, Nkomo VT, Vatury O, et al. Clinical outcome of isolated tricus- pid regurgitation. JACC Cardiovasc Imaging. 2014;7:1185 94. 3. Lee J-W, Song J-M, Park JP, et al. Long-term prognosis of isolated signifi- cant tricuspid regurgitation. Circ J. 2010;74:375 80. 4. 